Questions? Email us at [email protected].
Jim Yukevich and Yukevich Cavanaugh Donation Helps Generate 1.1 Million Meals
Long-time supporters of the LA Regional Food Bank, Jim Yukevich, his law firm, Yukevich Cavanaugh, members of the LA legal community, and other people in his circle have again demonstrated their incredible generosity with a financial contribution large enough to create the equivalent of 1.1 million meals for people who face food insecurity in Los Angeles County.
Deirdre McGlinchey Honored in 2022 Irish Legal 100
NEW ORLEANS (December 7, 2022) — McGlinchey Stafford is proud to announce that Deirdre McGlinchey has been named to the 2022 Irish Legal 100. The award reception took place in Washington, DC at the home of the Irish Ambassador to the United States on October 19.
Deirdre, a dual citizen of the United States and Ireland, was previously named to the
Irish Legal 100 in 2016, making this her second time to receive the honor. She has been
involved with numerous Irish American organizations, including the Irish American
Business Chamber & Network, Irish American Cultural Institute, American Irish
Historical Society, and Irish Network New Orleans. Deirdre has also proudly served as
the Honorary Consul for the Kingdom of the Netherlands since 2017. Deirdre regularly
represents domestic and international clients in product liability cases involving
individual claims, class actions, and multidistrict litigation. She has handled matters
involving construction, mining, and agricultural equipment; diesel and natural gas
engines; industrial turbines; automotive design; marine propulsion systems; toxic torts;
and medical devices. She has tried cases in state and federal courts throughout the
The Irish Legal 100 was founded in 2008 by the Irish Voice newspaper in New York. The
annual compilation highlights the most distinguished legal professionals in the United
States who share one common bond: pride in their Irish roots. The list includes
attorneys, legal scholars, and members of the judiciary who have distinguished
themselves in their fields of endeavor. Members include U.S. Supreme Court Chief Justice
John Roberts, Justice Anthony Kennedy, former U.S. Ambassador to Ireland Kevin O’Malley,
Georgetown Law Dean William Treanor, CBS News correspondent Erin Moriarty and many more,
including attorneys from some of the country’s top law firms.
Date of Decision: May 1, 2023
Issue: Whether the district court erroneously relied on this case’s status as an MDL proceeding as a basis for class certification.
Beneficial Party for Amicus Brief: Aurobindo Pharma Ltd.; Aurobindo Pharma USA, Inc.; Aurolife Pharma LLC; Camber Pharmaceuticals, Inc.; Hetero Drugs, Ltd.; Hetero Labs Ltd.; Hetero USA Inc.; Mylan Laboratories, Ltd.; Mylan NV; Mylan Pharmaceuticals, Inc.; Optum, Inc.; Optum Rx; Actavis LLC; Actavis Pharma, Inc.; Teva Pharmaceuticals USA, Inc.; Teva Pharmaceutical Industries Ltd.; Torrent Pharmaceuticals Ltd.; Torrent Pharma Inc.; Zhejiang Huahai Pharmaceutical Co., Ltd.; Huahai U.S., Inc.; Prinston Pharmaceutical Inc.; Solco Healthcare U.S., LLC; McKesson; AmerisourceBergen; Rite Aid; CVS; Walgreens; Walmart; Express Scripts; and Humana.
Background: This is an MDL proceeding involving drugs containing valsartan, an anti-hypertensive. In certifying three classes, the district court repeatedly relied on this matter’s status as an MDL proceeding as a justification for class certification. The defendants requested leave to appeal the class certification order under Rule 23(f).
Result: The Third Circuit denied leave to appeal.
Significance: The decision underscores the difficulty in persuading circuit courts to accept immediate review of class-certification orders, even where, as here, the order rests on legally questionable grounds.
On October 15, 2021, PLAC filed an amicus brief in the Supreme Court of the State of Connecticut on
behalf of Defendant-Appellees Bausch & Lomb, Inc., Bausch Health Companies Inc. (f/k/a Valeant
Pharmaceuticals International, Inc.), Bausch Health US, LLC (f/k/a Valeant Pharmaceuticals North America
LLC), and Bausch Health Americas, Inc. (f/k/a Valeant Pharmaceuticals International)
This brief was authored by John
Rotondo & Matthew
Letten of Day Pitney LLP
PLAC filed an amicus curiae brief on Nov. 22, 2021 in support of General Motors in this case.
The brief was
written by Phil Goldberg
Anna Pieschel of Shook Hardy & Bacon, LLP. The Court issued its ruling on June
Advances in battery-powered consumer electronics have long been enabling innovation in medical devices. As the performance, quality, and reliability of commercial batteries improve, their use in applications ranging from wearables to implantables has become commonplace. Many medical device manufacturers make commercial electronics batteries their first choice for product integration, but while commercial batteries offer significant benefits in cost and time, they are far from plug-and-play.
A Women's History Month podcast panel, presented by PLAC’s Women's Forum. This podcast was recorded live on March 22, 2023, hosted by PLAC member M.C. Sungaila and featuring Orange County Superior Court Presiding Judge Maria Hernandez, Orange County Supervisor Katrina Foley, Jennifer Keller of Keller Anderle, General Counsel of Origence Erin Wilson, and Trellis Legal Research co-founder Nicole Clark. Listen now.
As an organization representing many target defendants in mass tort MDLs, including some of the largest MDLs on the federal docket, the Product Liability Advisory Council is uniquely positioned to serve as a voice for the defense bar to improve defense messaging, align on strategy, and enhance opportunities to affect MDL processes in a meaningful way. PLAC’s Healthcare and Lifesciences Technology Group assembled a task force of outside and in-house counsel with deep experience in MDL litigation to evaluate some of the issues and challenges facing defendants and to develop strategies for effective, consistent approaches to these cases.
We return to a theme we’ve repeated twice before, in 2011 and in 2014 – that in addition to industry-specific groups, manufacturers of prescription medical products should definitely consider joining the Product Liability Advisory Council (“PLAC”). We continue to believe that PLAC membership helps pharmaceutical and medical device defendants litigate stronger (through inter-industry cooperation on shared issues of concern), smarter (through cutting edge CLE and webinars), and more efficiently (utilizing PLAC’s online knowledge base and other resources).
Jim Beck, Esq.
Reed Smith LLP
PLAC's mission is to obtain fairness and balance in the common law of product liability. A primary tool to accomplish this mission is PLAC's Amicus Curiae Program, often called “The heart and soul of PLAC.”
PLAC has filed more than 1,200 amicus briefs, written by some of the nation’s top appellate practitioners. Our briefs have been accepted in virtually every state and federal court in the U.S. They are routinely acknowledged, quoted, and praised by courts in published opinions.
PLAC’s amicus briefs help shape the law for all manufacturers on important issues.
PLAC 2021 Amicus Year in Review
PLAC is a specialty bar association focusing on complex litigation and regulatory issues in the area of product development and product liability. Our not-for-profit association of product manufacturers, suppliers, retailers and select regulatory, litigation and appellate professionals who work to shape the common law of product liability and complex regulation, provide guidance on changing regulations, and strategically help corporations manage risk throughout the entire product lifecycle. PLAC is a unique resource for companies who must defend their products’ integrity and their companies’ reputation.
Connect with us on LinkedIn